285 related articles for article (PubMed ID: 20174680)
21. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis.
Kumar D; Nath L; Kamal MA; Varshney A; Jain A; Singh S; Rao KV
Cell; 2010 Mar; 140(5):731-43. PubMed ID: 20211141
[TBL] [Abstract][Full Text] [Related]
22. Host versus pathogen: two sides of the same challenge in the TB world.
Cooper AM
Eur J Immunol; 2009 Mar; 39(3):632-3. PubMed ID: 19283712
[No Abstract] [Full Text] [Related]
23. Metallobiology of host-pathogen interactions: an intoxicating new insight.
Botella H; Stadthagen G; Lugo-Villarino G; de Chastellier C; Neyrolles O
Trends Microbiol; 2012 Mar; 20(3):106-12. PubMed ID: 22305804
[TBL] [Abstract][Full Text] [Related]
24. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis.
Tobin DM; Ramakrishnan L
Cell Microbiol; 2008 May; 10(5):1027-39. PubMed ID: 18298637
[TBL] [Abstract][Full Text] [Related]
25. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
Salgame P
Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
[TBL] [Abstract][Full Text] [Related]
26. A mathematical model of the initial interaction between Mycobacterium tuberculosis and macrophages.
Pienaar E; Lerm M
J Theor Biol; 2014 Feb; 342():23-32. PubMed ID: 24112967
[TBL] [Abstract][Full Text] [Related]
27. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
[TBL] [Abstract][Full Text] [Related]
28. Dissecting host factors that regulate the early stages of tuberculosis infection.
Agrawal N; Bhattacharyya C; Mukherjee A; Ullah U; Pandit B; Rao KVS; Majumder PP
Tuberculosis (Edinb); 2016 Sep; 100():102-113. PubMed ID: 27553417
[TBL] [Abstract][Full Text] [Related]
29. Human phagocytes lack the ability to kill Mycobacterium gordonae, a non-pathogenic mycobacteria.
Reyes-Ruvalcaba D; González-Cortés C; Rivero-Lezcano OM
Immunol Lett; 2008 Feb; 116(1):72-8. PubMed ID: 18160107
[TBL] [Abstract][Full Text] [Related]
30. [Mycobacterium tuberculosis--intracellular pathogen. Relationship between mycobacteria and the host].
Vrba A; Kwiatkowska S
Pol Merkur Lekarski; 2009 Dec; 27(162):508-13. PubMed ID: 20120719
[TBL] [Abstract][Full Text] [Related]
31. Human host response to Mycobacterium tuberculosis.
Rom WN; Schluger N; Law K; Condos R; Zhang Y; Weiden M; Harkin T; Tchou-Wong KM
Schweiz Med Wochenschr; 1995 Nov; 125(45):2178-85. PubMed ID: 8525336
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis.
Neyrolles O; Guilhot C
Tuberculosis (Edinb); 2011 May; 91(3):187-95. PubMed ID: 21330212
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium tuberculosis effectors involved in host-pathogen interaction revealed by a multiple scales integrative pipeline.
Li W; Fan X; Long Q; Xie L; Xie J
Infect Genet Evol; 2015 Jun; 32():1-11. PubMed ID: 25709069
[TBL] [Abstract][Full Text] [Related]
34. [Factors for the onset of and the exacerbation of tuberculosis. 2. Host factors promoting the occurrence and exacerbation of tuberculosis: significance of Th1-Th2 cytokine balance].
Kawakami K
Kekkaku; 1999 Oct; 74(10):735-40. PubMed ID: 10565134
[TBL] [Abstract][Full Text] [Related]
35. In vitro systems for studying the interaction of fungal pathogens with primary cells from the mammalian innate immune system.
Bourgeois C; Majer O; Frohner I; Kuchler K
Methods Mol Biol; 2009; 470():125-39. PubMed ID: 19089381
[TBL] [Abstract][Full Text] [Related]
36. Persistent bacterial infections: the interface of the pathogen and the host immune system.
Monack DM; Mueller A; Falkow S
Nat Rev Microbiol; 2004 Sep; 2(9):747-65. PubMed ID: 15372085
[TBL] [Abstract][Full Text] [Related]
37. Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110.
Rajavelu P; Das SD
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):95-102. PubMed ID: 15985228
[TBL] [Abstract][Full Text] [Related]
38. Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.
Ankley L; Thomas S; Olive AJ
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094248
[TBL] [Abstract][Full Text] [Related]
39. Modulation of cAMP metabolism in Mycobacterium tuberculosis and its effect on host infection.
Barba J; Alvarez AH; Flores-Valdez MA
Tuberculosis (Edinb); 2010 May; 90(3):208-12. PubMed ID: 20382084
[TBL] [Abstract][Full Text] [Related]
40. Role of glycans and glycoproteins in disease development by Mycobacterium tuberculosis.
Sonawane A; Mohanty S; Jagannathan L; Bekolay A; Banerjee S
Crit Rev Microbiol; 2012 Aug; 38(3):250-66. PubMed ID: 22324751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
